Acta Oto-Laryngologica · 2014 · 60 citations · 15 references
MedicineEndocrinologyOncologyEndocrine OncologyNeoplasiaPediatric EndocrinologyAngiogenesisEndocrine TumorsHormone ReceptorsSteroid Hormone SignalingAndrogen Receptor ExpressionEstrogen Receptor ExpressionNuclear Hormone ReceptorsReceptorsVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptor SignalingVascular Endothelial Growth Factor ReceptorsVascular Endothelial Growth Factor Signaling
CONCLUSION: This work demonstrated that juvenile nasopharyngeal angiofibromas (JNAs) express high levels of hormone receptors and vascular endothelial growth factor (VEGF) compared with normal nasal mucosa. The interaction between hormone receptors and VEGF may be involved in the initiation and growth of JNA. OBJECTIVES: JNA is a rare benign tumor that occurs almost exclusively in male adolescents. Although generally regarded as a hormone-dependent tumor, this has not been proven in previous studies. The aim of this study was to investigate the role of hormone receptors in JNA and the relationship with clinical characteristics. METHODS: Standard immunohistochemical microarray analysis was performed on 70 JNA samples and 10 turbinate tissue samples. Specific antibodies for androgen receptor (AR), estrogen receptor-α (ER-α), estrogen receptor-β (ER-β), progesterone receptor (PR), and VEGF were examined, and the relationships of receptor expression with age, tumor stage, and bleeding were evaluated. RESULTS: RESULTS showed that JNA expressed ER-α (92.9%), ER-β (91.4%), AR (65.7%), PR (12.8%), and VEGF (95.7%) at different levels. High level of VEGF was linked to elevated ER-α and ER-β. There was no significant relationship between hormonal receptors and age at diagnosis, tumor stage or bleeding. However, overexpression of ER-α was found to be an indicator of poor prognosis (p = 0.031).
15
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Juha Kononen, Lukas Bubendorf, Anne Kallionimeni et al. · Nature Medicine · 1998 · 4.1K citations
Angiofibroma: Changes in Staging and Treatment
Diana Radkowski, Trevor J. McGill, Gerald B. Healy et al. · Archives of Otolaryngology - Head and Neck Surgery · 1996 · 369 citations
Flutamide‐induced regression of angiofibroma
George A. Gates, Dale H. Rice, Charles F. Koopmann et al. · The Laryngoscope · 1992 · 91 citations
Pharmacy, Oncology, Pharmacology +9
Hormonal receptors in juvenile nasopharyngeal angiofibroma
M. Mokhtar Farag, S. E. Ghanimah, A. Ragaie et al. · The Laryngoscope · 1987 · 77 citations
Medicine, Endocrinology, Oncology +16